top of page

Research And Developement

Research and Development (R&D) is a crucial component of our strategy to become an integrated pharmaceutical industry leader. We recognize that R&D is vital for our growth, particularly in the fields of biotechnology and original drug research. Our commitment to innovation and scientific advancement drives us to invest in cutting-edge research, enabling us to develop new and effective treatments.

Formulation Development

Our aim is to develop new formulations and dosage forms for novel drugs, as well as to create variants of existing dosage forms. Additionally, we seek to introduce drug combinations by thoroughly understanding the mechanisms of interaction and the combined effects. This involves increasing the intensity of therapeutic responses, reducing adverse effects, and optimizing absorption. Through these efforts, we strive to enhance the efficacy and safety of our medications.

New Drug Delivery System

We are focused on developing innovative delivery systems, such as nanoparticles and controlled drug delivery systems. These advancements aim to improve patient compliance, reduce the total drug dosage needed, enhance treatment efficiency, and ensure cost-effectiveness. By leveraging these cutting-edge technologies, we strive to offer superior therapeutic solutions that benefit both patients and healthcare providers.

Bio-equivalence Studies

Adharava Pharmaceuticals is guided by a vision to establish a substantial presence in proprietary prescription products within the pharmaceutical market. Our focus is on advancing healthcare through the development of effective and safe medicines driven by technological innovation. Customer satisfaction is at the core of our business philosophy, ensuring that we deliver value and quality in all aspects of our products and services.

Process Developement

One of our primary objectives is to develop indigenous processes for new drugs initially introduced in developed countries. Our aim is to manufacture these drugs and introduce them into numerous countries swiftly, particularly targeting non-regulatory markets. This approach allows us to expand access to essential medications globally while maintaining stringent quality standards and ensuring timely supply to meet healthcare demands.

bottom of page